Melasma: A comprehensive update: Part II

Vaneeta M. Sheth, Amit G. Pandya

Research output: Contribution to journalArticle

126 Citations (Scopus)

Abstract

Several methods of treatment are available to patients with melasma. First-line therapy usually consists of topical compounds that affect the pigment production pathway, broad-spectrum photoprotection, and camouflage. Second-line therapy often consists of the addition of chemical peels, although these must be used cautiously in patients with darker skin. Laser and light therapies represent potentially promising options for patients who are refractory to other modalities, but also carry a significant risk of worsening the disease. A thorough understanding of the risks and benefits of various therapeutic options is crucial in selecting the best treatment.

Original languageEnglish (US)
Pages (from-to)699-714
Number of pages16
JournalJournal of the American Academy of Dermatology
Volume65
Issue number4
DOIs
StatePublished - Oct 2011

Fingerprint

Melanosis
Therapeutics
Phototherapy
Laser Therapy
Skin

Keywords

  • chemical peels
  • chloasma
  • hydroquinone
  • laser therapy
  • melasma
  • pigmentation

ASJC Scopus subject areas

  • Dermatology

Cite this

Melasma : A comprehensive update: Part II. / Sheth, Vaneeta M.; Pandya, Amit G.

In: Journal of the American Academy of Dermatology, Vol. 65, No. 4, 10.2011, p. 699-714.

Research output: Contribution to journalArticle

Sheth, Vaneeta M. ; Pandya, Amit G. / Melasma : A comprehensive update: Part II. In: Journal of the American Academy of Dermatology. 2011 ; Vol. 65, No. 4. pp. 699-714.
@article{214507779e5c4e1fbb39a35d812c6be6,
title = "Melasma: A comprehensive update: Part II",
abstract = "Several methods of treatment are available to patients with melasma. First-line therapy usually consists of topical compounds that affect the pigment production pathway, broad-spectrum photoprotection, and camouflage. Second-line therapy often consists of the addition of chemical peels, although these must be used cautiously in patients with darker skin. Laser and light therapies represent potentially promising options for patients who are refractory to other modalities, but also carry a significant risk of worsening the disease. A thorough understanding of the risks and benefits of various therapeutic options is crucial in selecting the best treatment.",
keywords = "chemical peels, chloasma, hydroquinone, laser therapy, melasma, pigmentation",
author = "Sheth, {Vaneeta M.} and Pandya, {Amit G.}",
year = "2011",
month = "10",
doi = "10.1016/j.jaad.2011.06.001",
language = "English (US)",
volume = "65",
pages = "699--714",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Melasma

T2 - A comprehensive update: Part II

AU - Sheth, Vaneeta M.

AU - Pandya, Amit G.

PY - 2011/10

Y1 - 2011/10

N2 - Several methods of treatment are available to patients with melasma. First-line therapy usually consists of topical compounds that affect the pigment production pathway, broad-spectrum photoprotection, and camouflage. Second-line therapy often consists of the addition of chemical peels, although these must be used cautiously in patients with darker skin. Laser and light therapies represent potentially promising options for patients who are refractory to other modalities, but also carry a significant risk of worsening the disease. A thorough understanding of the risks and benefits of various therapeutic options is crucial in selecting the best treatment.

AB - Several methods of treatment are available to patients with melasma. First-line therapy usually consists of topical compounds that affect the pigment production pathway, broad-spectrum photoprotection, and camouflage. Second-line therapy often consists of the addition of chemical peels, although these must be used cautiously in patients with darker skin. Laser and light therapies represent potentially promising options for patients who are refractory to other modalities, but also carry a significant risk of worsening the disease. A thorough understanding of the risks and benefits of various therapeutic options is crucial in selecting the best treatment.

KW - chemical peels

KW - chloasma

KW - hydroquinone

KW - laser therapy

KW - melasma

KW - pigmentation

UR - http://www.scopus.com/inward/record.url?scp=80052786607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052786607&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2011.06.001

DO - 10.1016/j.jaad.2011.06.001

M3 - Article

C2 - 21920242

AN - SCOPUS:80052786607

VL - 65

SP - 699

EP - 714

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

IS - 4

ER -